About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...

Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the best defensive stocks to buy, according to Steve Cohen. On August 25, the company announced it had reached an agreement to acquire Dutch coffee and tea company JDE Peet’s. Keurig Dr Pepper Inc. (KDP) Strengthens Coffee Business with JDE Peet’s Acquisition Copyright: tunedin123 / 123RF Stock Photo The $18 billion deal is expected to be part of the company’s push to bolster its struggling US Coffee business. In the second quarter, revenue in the coffee busi ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best defensive stocks to buy, according to Steve Cohen. On September 7, the company announced positive clinical trial results involving Tagrisso in combination with pemetrexed and platinum-based chemotherapy. AstraZeneca PLC (AZN) Receives Tagrisso Boost in Lung Cancer Trials Pixabay/Public Domain The trial results showed that the combination extended the lives of some lung cancer patients by a median of 47.5 months. It is the longest survival benefit ever reco ...

The Procter & Gamble Company (NYSE:PG) is one of the best defensive stocks to buy, according to Steve Cohen. On September 4, at the Barclays 18th Annual Global Consumer Staples Conference 2025, the company reiterated its commitment to leveraging innovation and efficiency to drive future growth. The Procter & Gamble Company (PG) Focused on Innovation and Efficiency to Accelerate Growth Copyright: jetcityimage / 123RF Stock Photo As the global market growth is expected to stabilize between 2% and 2.5% bel ...

Eli Lilly and Co. (NYSE:LLY) is one of the best defensive stocks to buy, according to Steve Cohen. On September 9, the company announced the launch of an artificial intelligence and machine learning platform. Eli Lilly and Company (LLY) Unveils AI Platform to Enhance Drug Discovery Pixabay/Public Domain TuneLab is the platform that consists of AI models and proprietary data obtained at a cost of more than $1 billion. The platform is designed to provide biotech companies with all the necessary models tra ...

Chewy Inc. (NYSE:CHWY) is one of the best defensive stocks to buy, according to Steve Cohen. On September 10, the company delivered solid second-quarter results characterized by sales coming in at the high end of the guidance range. Chewy Inc. (CHWY) Posts Impressive Q2 Results on Revenue Growth The company reported net sales of $3.1 billion, representing an 8.6% year-over-year increase, as gross margins improved by 90 basis points to 30.4%. Adjusted net income increased by $36.4 million year over year t ...

The Coca-Cola Company (NYSE:KO) is one of the best defensive stocks to buy, according to Steve Cohen. On September 3 at the Barclays 18th Annual Global Consumer Staples Conference 2025, the company reiterated plans to focus on innovation and digital transformation. The Coca-Cola Company (KO) Doubles Down on Digital and Emerging Markets for Long-Term Growth urbanbuzz / Shutterstock.com The beverage giant is prioritizing digital transformation as it looks to bolster its competitive edge in the industry. C ...

Boston Scientific Corporation (NYSE:BSX) is one of the best defensive stocks to buy, according to Steve Cohen. On September 8, analysts at Oppenheimer upgraded the stock to an ‘Outperform’ from Perform and reiterated a $125 price target. Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech Image: Courtesy of Boston Scientific The upgrade comes as Oppenheimer views the company as one of the best large-cap MedTech growth stories owing to a robust merger and acquisition strat ...

Biogen Inc. (NASDAQ:BIIB) is one of the best defensive stocks to buy, according to Steve Cohen. On September 5, H.C. Wainwright reiterated a ‘Buy’ rating on the stock and a $194 price target. The positive stance echoes the research firm’s confidence about the company’s promising lupus franchise. H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects According to H.C. Wainwright, the lupus treatments litifilimab and dapirolizumab pegol are compelling late-stage assets that unde ...

CEMEX, S.A.B. de C.V. (NYSE:CX) is one of the best cement stocks to buy according to analysts. On September 3, analysts at BofA Securities reiterated a ‘Neutral’ rating on the stock and lifted the price target to $10 and $8.60. The price target hike underscores BofA’s updated discounted cash flow analysis based on 2026 projections. BofA Securities Lifts CEMEX, S.A.B. de C.V. (CX) Price Target on Capital Return Plans The price target hike comes as Cemex outperforms cement stocks over the past six months, ...